Revolution Medicines is a global, commercial-stage oncology company dedicated to discovering, developing, and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide. Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency, and hold ourselves to a high standard of rigor—all in service of patients. The Opportunity: The Sr. Director of Global Planning will shape and lead the global planning strategy for a growing portfolio of late-stage clinical and commercial programs. This is a high-impact opportunity to build scalable, end-to-end supply planning capabilities that ensure reliable delivery of small molecule drug substance, drug product, and packaging and labeling to patients worldwide. The role will lead S&OP and D&OP, drive inventory and supply strategies, enable launch readiness, and partner across functions to strengthen an expanding global supply network. The successful candidate will combine strategic vision with operational rigor to establish the processes, systems, and cross-functional alignment needed to achieve exceptional supply reliability.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior